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CLINICAL REPORT
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Abstract
Iron-sulfur (Fe-S) clusters are a class of highly conserved and ubiquitous prosthetic groups with unique chemical properties that allow the proteins that contain them, Fe-S proteins, to assist in various key biochemical pathways.
Mutations in Fe-S proteins often disrupt Fe-S cluster assembly leading to a
spectrum of severe disorders such as Friedreich’s ataxia or iron-sulfur cluster
assembly enzyme (ISCU) myopathy. Herein, we describe infantile mitochondrial
complex II/III deficiency, a novel autosomal recessive mitochondrial disease
characterized by lactic acidemia, hypotonia, respiratory chain complex II and
III deficiency, multisystem organ failure and abnormal mitochondria. Through
autozygosity mapping, exome sequencing, in silico analyses, population studies
and functional tests, we identified c.215G>A, p.Arg72Gln in NFS1 as the likely
causative mutation. We describe the first disease in man likely caused by deficiency in NFS1, a cysteine desulfurase that is implicated in respiratory chain
function and iron maintenance by initiating Fe-S cluster biosynthesis. Our
results further demonstrate the importance of sufficient NFS1 expression in
human physiology.
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Iron-sulfur (Fe-S) clusters are a class of ubiquitous prosthetic groups thought to be highly conserved in essentially
all organisms (Sheftell et al. 2010). Their unique chemical
properties allow the proteins that contain them to assist

in vital and diverse biochemical pathways such as iron
metabolism and homeostasis as well as DNA damage
repair (Kispal et al. 1999; Rudolf et al. 2006; Lill et al.
2012). Eukaryotic Fe-S proteins are localized to the mito-
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chondria (Lill et al. 2012), cytosol (Tong and Rouault
2006), endoplasmic reticulum (Lill et al. 2006), and
nucleus (Naamati et al. 2009). Fe-S proteins initiate biogenesis of the Fe-S cluster complex, which can transfer
electrons, act as catalysts, stabilize protein structures, and
execute regulatory functions (Kispal et al. 1999; Rudolf
et al. 2006). Given the central role of Fe-S clusters in
many fundamental biochemical pathways, deficiency in
genes encoding Fe-S proteins are expected to cause
human disease. Classic examples of Fe-S cluster deficiency
related to human disease include the following: Friedreich’s ataxia (FRDA [MIM 229300]), the most common
autosomal recessive ataxia due to a homozygous expansion of a GAA trinucleotide repeat in intron 1 of FXN
(GenBank accession number, NM_000144.4) (Koeppen
2011) and ISCU myopathy [MIM 255125], due to a splicing defect in ISCU (GenBank accession number,
NM_213595.2) that alters the C-terminus ultimately
reducing protein expression (Kollberg et al. 2009). Other
Fe-S cluster-related diseases include those caused by
mutations in NFU1 (GenBank accession number,
NM_015700.3) or BOLA3 (GenBank accession number,
NM_212552.2), which ultimately disrupt Fe-S enzyme
lipoate synthase activity (Cameron et al. 2011). This leads
to a severe infantile multisystem disorder known as multiple mitochondrial dysfunctions syndrome, which is characterized by hyperglycinemia, lactic acidosis, hypertension,
and failure to thrive (Cameron et al. 2011).
The interaction network of proteins involved in Fe-S
cluster assembly is becoming clearer in both yeast and
mammalian cells. In particular, NFS1 (MIM# 603485, GenBank accession number, NM_021100.4), ISCU, ISD11
(GenBank accession number, NM_020408.4), and FXN
form the Fe-S cluster core complex (Prischi et al. 2010; Bridwell-Rabb et al. 2011; Schmucker et al. 2011; Rouault
2012). Fe-S cluster formation begins with NFS1 forming a
homodimer to which monomers of a scaffold protein
ISCU, bind near the top and the bottom (Shi et al. 2010).
A cofactor pyridoxal 5’ phosphate, helps NFS1 provide
inorganic sulfur from cysteine residues, which then bind to
cysteine ligands supplied by ISCU, that further covalently
bind to iron (Raulfs et al. 2008). The core complex then
recruits NFS1-binding protein, ISD11 (Adam et al. 2006)
and finally FXN (Prischi et al. 2010). Next, the Fe-S cluster
is transferred to recipient apo-proteins via binding of ISCU
to chaperone proteins (Craig and Marszalek 2002). In
short, it is clear that Fe-S cluster assembly is a highly conserved multistep process requiring cysteine desulfurases,
scaffold proteins, chaperones, and iron donors to ultimately maintain iron homeostasis, execute catalysis, and
regulate gene expression (Lill et al. 2012; Rouault 2012).
Here, we report a rare genetic mitochondrial disorder designated as infantile mitochondrial complex II/III
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deficiency (IMC23D), characterized by lactic acidemia,
hypotonia, respiratory chain complex II and III deficiency,
multisystem organ failure, and abnormal mitochondria
affecting three children of healthy third cousins within an
Old Order Mennonite community. The first child was
admitted at 7 months of age. She was dehydrated and
hypoglycemic after suffering a brief episode of pharyngitis. One day prior to admission, she presented with lethargy, anorexia, and oliguria. She had a generalized seizure
followed by metabolic acidosis, respiratory decompensation, and severe myocardial failure. Her blood lactate, liver
enzymes, and amylase levels were elevated (Table 1). She
developed persistent hypotension, worsening oliguria, and
peripheral edema. She died of cardiac failure 3 days post
admission.
The second child was admitted with respiratory failure
and cyanosis at 6 weeks of age. He was normoglycemic but
had elevated levels of lactate, aspartate aminotransferase
(AST), and creatine kinase (CK) (Table 1). At 15 weeks, he
was readmitted with truncal hypotonia, feeding problems,
vomiting, and acidosis. He developed multisystem organ
failure including cardiorespiratory failure, which required
intubation, ventilation, and inotropic support. He had focal
seizures with cerebral infarction documented by computed
topography, renal failure, and disseminated intravascular
coagulation. He was treated with a mitochondrial cofactor
therapy consisting of riboflavin (50 mg twice daily [BID]),
coenzyme Q10 (30 mg BID), thiamine (50 mg BID), vitamin C (100 mg BID), vitamin E (400 IU once daily [OD]),
and vitamin K (2 mg OD), which led to a rapid and substantial clinical and biochemical improvement allowing extubation and discharge from the hospital. He did continue
to have mild hypotonia. At 7 months, symptoms reoccurred; he worsened rapidly and died of cardiac failure
3 days post admission, despite intensive treatment.
A third child was born to the couple and was monitored for the same suspected mitochondrial disease. Neonatal neurological examination revealed symmetrical mild
hypotonia of the upper limbs and to a lesser extent, of
the lower limbs. He had symptoms in infancy consistent
with those observed in his siblings, which included hypotonia, lethargy, weight loss, and abnormal lactate levels
(Table 1). Similarly, he was treated with a mitochondrial
cofactor therapy from 6 months until about 11 years of
age. He is generally healthy today. However, his blood
lactate, AST, and CK levels remain elevated (Table 1).
While he has no history of seizures or problems related
to his heart, he still has some mild developmental and
gross motor delay, consisting primarily of a minor tremor
and overall low energy. The lactic acidemia has persisted
albeit fluctuated, for ~8 years but has recently abated.
The results of metabolite analyses in all three children
support the diagnosis of a mitochondrial disease.
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Table 1. Clinical and biochemical description of patients with IMC23D.
Affected Individuals (year of birth)
Clinical features
Gestation
Gender
Karyotype
Facial/limb dysmorphology
Lethargy/anorexia/hypotonia
Autopsy
Age at last assessment
Height (cm)
Weight (kg)
Associated diagnoses
Respiratory failure
Cardiac failure
Hemorrhagic pancreatitis
Cerebral infarction
Renal failure
Disseminated intravascular coagulation
Seizures
Differential diagnoses
Mitochondrial encephalomyopathy,
lactic acidosis, and stroke-like episodes
(MELAS), c.3243A>G
Myopathy, c.3260A>G
Cardiomyopathy, c.3303C>T
Myoclonic Epilepsy with Ragged Red
Fibers (MERF), c.8344A>G
Neurogenic muscle weakness, Ataxia,
and Retinitis Pigmentosa (NARP)/Leigh
syndrome, c.9883T>G/C
Biochemical Findings
Hypoglycemia
Increased lactate (normal: 0.5–2.2 mmol/L)
Increased aspartate aminotransferase
Increased amylase
Increased creatine kinase
Increased plasma amino acid concentration
Urine organic acids
Amino aciduria
Metabolic acidosis
Respiratory chain enzymes
Muscle mitochondria (nmoles/min/mg)
Complex I + III (range: 37–99, mean: 71)
Complex II + III (range: 85–214, mean: 152)
Complex IV (range: 193–354, mean: 264)
Citrate synthase (range: 170–481, mean: 339)
Liver mitochondria (nmoles/min/mg)
Complex I + III (range: 2–14, mean: 7)
Complex II + III (range: 18–70, mean: 45)
Complex IV (range: 15–100, mean: 41)
Citrate synthase (range: 15–53, mean: 33)
N, normal; +, present;

IV-I (1992)
Full term
Female
46,XX

IV-II (1994)
Full term
Male
46,XY

IV-III (1999)
Full term
Male
46,XY

+
+
7 months, deceased

+
+
7 months, deceased

+
+
12 years
154.9 (50th percentile)
50 (75th–90th percentile)

+
+
+

+
+

+
+
+

+*
+
+
+*

+
+

+
+

+
+
+
+ (most amino acids)
+

+

+ (ranged between 4
and 6 mmol/L)
+

+

+
+
N
+
+

+
+ (small increase in Alanine)
+
+
+

23a
5a
156a
229a

33b, 29a
27a, 23b
181b, 111a
846b, 540a

7a
133a
39a
37a

19b
13b
35b
14b

, absent; aautopsy; bbiopsy; *at 15 weeks of age. Blank cells indicate unavailable information.

No specific findings relevant to the molecular abnormalities were noted from the general autopsy materials.
However, both cases (IV-I and IV-II) exhibited hepatic

steatosis, a common nonspecific finding in various,
including metabolic, disorders. Hemorrhagic pancreatitis
with secondary mesenteric fat necrosis, a nonspecific com-
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plication of “critical illness,” was present in individual IVI and there was evidence of acute myocardial ischemic
injury in individual IV-II, a common agonal finding. No
other definite histological abnormalities were noted in the
myocardium although this does not exclude the presence
of a significant mitochondrial disorder in the heart.
Under the light microscope, the majority of the muscle
fibers in the biopsy from individual IV-II were unusually
small and many of them contained small, faintly basophilic granules in the section stained with hematoxylin,
phloxin and saffron; these granules were magenta in the
section stained with gomori modified trichrome and
exhibited increased enzyme activity in the sections treated
with reduced nicotinamide adenine dinucleotide-tetrazolium reductase and cytochrome C oxidase histochemistry.
The succinic dehydrogenase activity was extremely weak
in comparison to normal controls. Focally prominent
subsarcolemmal collections of periodic acid-Schiff-positive
glycogen were observed (Fig. 1A).
Given the known consanguinity of the parents, we modeled an autosomal recessive mode of inheritance. Blood
and tissue samples were collected from the family following
appropriate and informed consent in accordance with the
Research Ethics Board at Western University. The detailed
materials and methods can be found elsewhere (see Methods in Data S1). Genome-wide autozygosity mapping generated a locus on chromosome 20p11.2-q13.1, ~27.7 Mb
with a highly significant location score of 1754 (Fig. 2B).
The long segment of homozygosity was unique to the
affected individuals and contained 4239 single nucleotide
polymorphisms (SNPs) belonging to 453 genes bordered by
SNPs rs4305333:A>C and rs6125184:A>G, which correspond to 20:18,891,229 and 20:46,576,714, respectively
(Fig. 2–A–C). Next, we applied whole-exome sequencing
and identified a novel variant within the autozygous region:
c.215G>A, p.Arg72Gln in NFS1, a highly conserved cysteine
desulfurase involved in the Fe-S cluster assembly machinery
and is essential for the maturation of other Fe-S proteins.
Nucleotide numbering reflects cDNA numbering with +1
corresponding to the A of the ATG translation initiation
codon in the reference sequence, according to journal
guidelines (www.hgvs.org/mutnomen). NFS1 p.Arg72Gln
cosegregates with disease status in the family and was consistently predicted to be damaging by multiple in silico
analyses. Exome sequencing identified additional coding
variants within other genes in the autozygous region with a
minor allelic frequency (MAF) >1%, however, given the
rarity of the disease, these variants were not further analyzed (Table S1).
To determine the MAF, we began by genotyping 40
otherwise healthy controls from the Old Order Mennonite community. We did not identify any carriers for
NFS1 c.215G>A, p.Arg72Gln, however, after genotyping
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3033 additional individuals from an ethnically diverse
cohort, we identified one heterozygote (0.016%), which
was consistent with the reported MAF in the NHLBI ESP
Exome Variant Server. Furthermore, we performed quantitative reverse transcriptase-polymerase chain reaction
(qRT-PCR) and Western analysis using fibroblast cells
from the affected individuals and observed markedly
reduced NFS1 transcript and protein levels relative to
those from a healthy control (Fig. 3B). Using enzymology
assays on muscle and liver tissue, we saw deficiency in
mitochondrial respiratory chain complex II and III, which
is consistent with decreased NFS1 protein levels and
likely, a disruption in Fe-S cluster assembly (Table 1).
Lastly, when wild-type and patient fibroblast cells were
subjected to co-immunoprecipitation with an antibody
against NFS1, ISD11 was co-precipitated with NFS1 in
wild-type but not in patient cells (Fig. S1). This suggests
that the NFS1-ISD11 complex is disrupted in patient cells.
Interestingly, mutations in LYRM4, which encodes ISD11,
also result in a compromised NFS1-ISD11 complex and
leads to a clinical presentation similar to IMC23D (Lim
et al. 2013).
During our analysis, we identified a second variant
within the autozygous region, c.499C>T, p.Arg167Cys in
CDH22 (GenBank accession number, NM_021248.2), a
calcium-dependent cell adhesion protein predominately
expressed in the brain (Sugimoto et al. 1996; SaarimakiVire et al. 2011). CDH22 p.Arg167Cys was predicted to
be pathogenic by in silico analyses, cosegregated with disease status in the family and has a MAF of 0.062%
according to NHLBI ESP Exome Variant Server. We performed qRT-PCR and Western analysis to determine the
effect of p.Arg167Cys in CDH22 on protein function,
however, we were unable to measure any CDH22 transcript and protein levels in patient fibroblast cells. Given
the nature of the protein in that it is predominantly
expressed in the brain, and has not been linked to mitochondrial dysfunction, we believe p.Arg167Cys in CDH22
is not involved in IMC23D and is in linkage disequilibrium with NFS1 p.Arg72Gln.
Until now three Fe-S proteins, namely NFS1, NBP35
(GenBank accession number, NM_002484.3), and IOP1
(GenBank accession number, NM_022493.1), had not
been linked to a human deficiency state (Sheftell et al.
2010). There are arguably two reasons for this: (1) such
disorders have not yet been ascertained; or (2) a deficiency in these vital and well-conserved gene products is
incompatible with life. Several studies have examined the
cellular localization of NFS1, its role in Fe-S cluster biogenesis and assembly, as well as its role in other pathways
such as donating sulfur to MOCS3 in the molybdenum
cofactor biosynthesis pathway (Marelja et al. 2008). However, two studies examined the physiological consequence
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Figure 1. Mapping and exome sequencing of autosomal recessive infantile mitochondrial complex II/III deficiency (IMC23D) family identifies a
highly conserved and destabilizing missense mutation, p.(Arg72Gln) in NFS1. (A) An Old Order Mennonite pedigree showing a union between
two healthy third cousins. Three out of four children are affected with IMC23D. Affected individuals are shown in shaded squares (male) and
circles (female). Diagonal lines across symbols indicate deceased individuals. A consanguineous marriage is shown by a double line between two
individuals. Horizontal dashes above symbols indicate individuals who underwent DNA analysis. Diamonds indicate unspecified genders. (B)
Genome-wide autozygosity mapping confirmed the autosomal recessive mode of inheritance by generating a long homozygous segment unique
to the affected individuals on chromosome 20p11.2-q13.1 with a highly significant location score of 1754. (C) Ideogram depicting the
homozygous segment unique to the affected individuals, Chromosome 20p11.2-q13.1, spanning 27.7 Mb. (D) The NFS1 gene consists of 13
coding exons with a nonsynonymous nucleotide change, c.215T>G in exon one. Nucleotide numbering reflects cDNA numbering with +1
corresponding to the A of the ATG translation initiation codon in the reference sequence, according to journal guidelines (www.hgvs.org/
mutnomen). The initiation codon is codon 1. (E) The structure of the NFS1 protein contains one domain, aminotransferase class V domain, shown
from the N-terminal to C-terminal end. The amino acid (aa) p.Arg72 is harbored within the aminotransferase class V domain. (F) Multiple
alignments demonstrate high conservation of the aa residue p.Arg72 across a set of species-specific NFS1 homologs. A ClustalW analysis of the
NFS1 region encompassing the mutation site at residue p.Arg72 (highlighted in red) in aligned homologs with multiple divergent species is
shown. The residues shaded in blue indicate fully conserved residues. (G) DNA sequence analysis of p.Arg72Gln from genomic DNA of a normal
individual (IV-IV, top left electropherogram), a homozygous individual (IV-I, IV-II, IV-III, bottom left electropherogram), and a p.Arg72Gln
heterozygous individual (III-V, III-VI, right electropherogram). For each electropherogram, amino acid codes are shown in the top line with
nucleotide sequence and codon numbers below. The position of the mutated nucleotide is underlined.

of cellular NFS1 depletion via small interfering RNA
(siRNA)-mediated gene silencing approaches and are of
particular interest (Biederbick et al. 2006; Fosset et al.
2006). In one study, depletion of mouse NFS1 (m-Nfs1)
in murine fibroblasts led to reduced activity of mitochondrial respiratory chain complex I and II and citric acid

cycle protein, aconitase (Fosset et al. 2006). Interestingly,
there was no change in mitochondrial malate dehydrogenase
activity or cytosolic lactate dehydrogenase, neither of which
contain Fe-S clusters (Fosset et al. 2006). The second
study showed severe growth retardation and morphological changes in mitochondria following NFS1 gene
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Figure 2. Pathological and cellular dysfunction in patients with infantile mitochondrial complex II/III deficiency (IMC23D). (A) Pathological findings
in patients with IMC23D. These electron micrographs show scattered lipid droplets (black arrows) and abundant glycogen (G), which are common
nonspecific findings. Note also the lack of capillaries (left) – there should be at least three but only one can be seen (C). The lipid droplets are
often close to directly or attached to the mitochondria (bottom right). There are a variety of mitochondrial abnormalities (white arrows), including
concentric cristae (top middle and right), a honeycomb arrangement of the cristae (top middle and right, bottom middle), vacuolated or ‘blown’
mitochondria reminiscent of artifacts but possibly also evidence of ‘metabolic fragility’ (bottom center), and finally scant cristae (bottom right).
Scale bars 2 lm (left), 1 lm (bottom center), 500 nm (top center and right, bottom right). (B) Depletion in NFS1 protein and transcript levels in
patients with IMC23D. Both (i) quantitative PCR and (ii) Western analysis show reduced NFS1 cellular expression in fibroblast cells of patients
affected with IMC23D. Bar graphs indicate means  standard deviations from two sets of experiments, showing the relative NFS1 expression in
affected individuals normalized to a healthy control quantified by densitometry. The autoradiographs provide a visual representation of NFS1
protein level. The upper blot shows decreased protein expression in NFS1 R72Q relative to NFS1 wild-type (WT). The lower blot shows the
constitutive expression of a-tubulin in both experiments.

silencing in HeLa cells (Biederbick et al. 2006). Similarly,
it showed decreased activity in both mitochondrial and
cytosolic Fe-S proteins (Biederbick et al. 2006). Interestingly, introduction of m-Nfs1 repaired growth and
restored Fe-S protein activity (Biederbick et al. 2006).
These findings are consistent with an NFS1-dependent
human deficiency state, as seen in our patients. Studies of
this type together with our findings shed light on the
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physiological significance of proper Fe-S cluster biogenesis
and assembly and their role in human health particularly,
Fe-S cluster-related diseases.
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Figure S1. NFS1-ISD11 interaction is disrupted in patient
cells. Wild-type and patient fibroblast cells were subjected
to co-immunoprecipitation with an antibody against
NFS1. ISD11 was co-precipitated with NFS1 in wild-type
(NFS1 WT) but not patient cells (NFS1 R72Q).
Table S1. Additional rare coding variants (MAF < 5%)
identified within the autozygous region, chromosome
20p11.2-q13.1.
Data S1. Supplementary materials and methods.
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